Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

K. D. Joode; H. J. M. Groen; A. A. M. van der Veldt; K. P. M. Suijkerbuijk; J. W. B. de Groot; R. de Wijn; D. P. Hurkmans; D. M. A. van den Heuvel; K. Schmidt; J. P. Groten; E. M. E. Verdegaal; S. H. van der Burg; M. M. van den Heuvel; J. G. J. V. Aerts; E. Kapiteijn; R. H. Mathijssen

doi:10.1016/j.annonc.2020.08.094

Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

K. D. Joode, H. J. M. Groen, A. A. M. van der Veldt, K. P. M. Suijkerbuijk, J. W. B. de Groot, R. de Wijn, D. P. Hurkmans, D. M. A. van den Heuvel, K. Schmidt, J. P. Groten, E. M. E. Verdegaal, S. H. van der Burg, M. M. van den Heuvel, J. G. J. V. Aerts, E. Kapiteijn, R. H. Mathijssen

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	S788-S788
Aantal pagina's	1
Tijdschrift	Annals of Oncology
Volume	31
DOI's	https://doi.org/10.1016/j.annonc.2020.08.094
Status	Published - sep.-2020
Evenement	ESMO Virtual Congress - Duur: 19-sep.-2020 → 18-okt.-2020

Toegang tot document

10.1016/j.annonc.2020.08.094

Handle.net

Permanente koppeling

Citeer dit

Joode, K. D., Groen, H. J. M., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., de Groot, J. W. B., de Wijn, R., Hurkmans, D. P., van den Heuvel, D. M. A., Schmidt, K., Groten, J. P., Verdegaal, E. M. E., van der Burg, S. H., van den Heuvel, M. M., Aerts, J. G. J. V., Kapiteijn, E., & Mathijssen, R. H. (2020). Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC. Annals of Oncology, 31, S788-S788. https://doi.org/10.1016/j.annonc.2020.08.094

@article{3ab80f0267c34dd09b6fa9147891d921,

title = "Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC",

author = "Joode, {K. D.} and Groen, {H. J. M.} and {van der Veldt}, {A. A. M.} and Suijkerbuijk, {K. P. M.} and {de Groot}, {J. W. B.} and {de Wijn}, R. and Hurkmans, {D. P.} and {van den Heuvel}, {D. M. A.} and K. Schmidt and Groten, {J. P.} and Verdegaal, {E. M. E.} and {van der Burg}, {S. H.} and {van den Heuvel}, {M. M.} and Aerts, {J. G. J. V.} and E. Kapiteijn and Mathijssen, {R. H.}",

year = "2020",

month = sep,

doi = "10.1016/j.annonc.2020.08.094",

language = "English",

volume = "31",

pages = "S788--S788",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "ESMO Virtual Congress ; Conference date: 19-09-2020 Through 18-10-2020",

}

Joode, KD, Groen, HJM, van der Veldt, AAM, Suijkerbuijk, KPM, de Groot, JWB, de Wijn, R, Hurkmans, DP, van den Heuvel, DMA, Schmidt, K, Groten, JP, Verdegaal, EME, van der Burg, SH, van den Heuvel, MM, Aerts, JGJV, Kapiteijn, E & Mathijssen, RH 2020, 'Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC', Annals of Oncology, vol. 31, blz. S788-S788. https://doi.org/10.1016/j.annonc.2020.08.094

TY - JOUR

T1 - Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC

AU - Joode, K. D.

AU - Groen, H. J. M.

AU - van der Veldt, A. A. M.

AU - Suijkerbuijk, K. P. M.

AU - de Groot, J. W. B.

AU - de Wijn, R.

AU - Hurkmans, D. P.

AU - van den Heuvel, D. M. A.

AU - Schmidt, K.

AU - Groten, J. P.

AU - Verdegaal, E. M. E.

AU - van der Burg, S. H.

AU - van den Heuvel, M. M.

AU - Aerts, J. G. J. V.

AU - Kapiteijn, E.

AU - Mathijssen, R. H.

PY - 2020/9

Y1 - 2020/9

U2 - 10.1016/j.annonc.2020.08.094

DO - 10.1016/j.annonc.2020.08.094

M3 - Meeting Abstract

SN - 0923-7534

VL - 31

SP - S788-S788

JO - Annals of Oncology

JF - Annals of Oncology

T2 - ESMO Virtual Congress

Y2 - 19 September 2020 through 18 October 2020

ER -